UnitedHealth Group Incorporated $UNH Stake Raised by Element Pointe Advisors LLC

Element Pointe Advisors LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 262.7% during the 2nd quarter, Holdings Channel reports. The fund owned 2,151 shares of the healthcare conglomerate’s stock after acquiring an additional 1,558 shares during the quarter. Element Pointe Advisors LLC’s holdings in UnitedHealth Group were worth $671,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of the business. Brighton Jones LLC boosted its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 7.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 3,889 shares of the healthcare conglomerate’s stock valued at $2,037,000 after purchasing an additional 283 shares in the last quarter. Tocqueville Asset Management L.P. raised its holdings in shares of UnitedHealth Group by 453.4% in the 1st quarter. Tocqueville Asset Management L.P. now owns 132,198 shares of the healthcare conglomerate’s stock worth $69,238,000 after purchasing an additional 108,309 shares in the last quarter. Finally, Boston Family Office LLC grew its position in UnitedHealth Group by 12.5% in the first quarter. Boston Family Office LLC now owns 5,805 shares of the healthcare conglomerate’s stock worth $3,040,000 after buying an additional 647 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. Barclays boosted their target price on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Bank of America raised their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Truist Financial boosted their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Finally, Morgan Stanley lifted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Seventeen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $385.54.

UnitedHealth Group Stock Up 1.5%

Shares of UNH stock opened at $341.83 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The stock’s 50 day simple moving average is $339.84 and its 200 day simple moving average is $317.07. The company has a market capitalization of $309.65 billion, a price-to-earnings ratio of 17.84, a PEG ratio of 2.23 and a beta of 0.43. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter last year, the firm posted $7.15 EPS. The business’s quarterly revenue was up 12.2% on a year-over-year basis. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.